Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03) The following represents disclosure information provided by authors ...

Researchers have developed a model of Kaposi sarcoma that could expedite the development of new drugs to treat the disease, which is the most common cancer in people living with HIV. Researchers at ...

In this multicenter phase I trial, we enrolled participants with HIV-associated KS on antiretroviral therapy with CD4 + ≥50 cells/μL and HIV plasma RNA <200 copies/mL. Pembrolizumab 200 mg ...

Researchers at UNC Lineberger Comprehensive Cancer Center, after decades of research efforts, have developed a mouse model of Kaposi sarcoma that could be key to the development of new drugs to treat ...

People with HIV may be at higher risk for cancers such as Kaposi sarcoma, non-Hodgkin lymphoma, and cervical cancer. Combination antiretroviral therapy (cART) may be the reason for the recent change ...

Viruses are masters of stealth, often lurking silently in our bodies. For the Kaposi sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus-8 (HHV-8), the human mouth serves as an ...

This is a preview. Log in through your library . Abstract Background. Mild-to-moderate AIDS-associated Kaposi sarcoma (KS) often responds to antiretroviral therapy (ART) alone; the role of ...

This article is brought to you by LSU LCMC Health Cancer Center. LSU LCMC Health Cancer Center researchers continue to make progress in discovering connections between HIV and certain cancers, and are ...

Dirk Dittmer, PhD, and colleagues have developed a model of Kaposi sarcoma could be key to the development of new drugs to treat the disease. Kaposi sarcoma is the most common cancer in people living ...